Our studies demonstrate that SMAD3 is important in the repair phase of DSS-induced colitis, as most 3% DSS-exposed Smad3−/− mice succumbed to disease prior to 5 weeks post DSS treatment. This evidence concerns the gene SMAD3 and colitis.